The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Mon., Dec. 22, 2:24 PM

Slide #2. Exact Sciences Corporation Secondary Offering

Company: Exact Sciences Corporation (NASDAQ:EXAS)
Date announced: 12/15/2014
Shares Offered: 4,000,000
Date of Pricing: 12/16/2014
Price Per Share: $25.75
Secondary Offering Details: Exact Sciences Corporation (NASDAQ:EXAS) today announced an agreement to sell 4,000,000 shares of its common stock to Jefferies LLC and Robert W. Baird & Co. Incorporated as underwriters in an underwritten public offering pursuant to its effective shelf registration statement previously filed with the Securities and Exchange Commission (the "SEC") on Form S-3. The Company has also granted the underwriters an option to purchase up to 600,000 additional shares. - updated 12/16 - Exact Sciences Corporation (NASDAQ:EXAS) today announced the pricing of the public offering of 4,000,000 common shares previously sold to Jefferies LLC and Robert W. Baird & Co. Incorporated, as underwriters of the offering. The common shares will be sold at a public offering price of $25.75 per share. The Company has also granted the underwriters an option to purchase up to 600,000 additional shares. The offering is expected to close on or about December 19, 2014, subject to customary closing conditions.

EXACT Sciences is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. Co. has developed a non-invasive screening test for the early detection of colorectal pre-cancer and cancer. Co.'s Cologuard® test is a non-invasive stool-based DNA screening test designed to detect DNA markers. Co.'s Cologuard test is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. In addition to DNA markers, Co.'s test includes a protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test.
Open the EXAS Page at The Online Investor »

Company Name:  EXACT Sciences Corp.
Sector:  Biotechnology
Number of ETFs Holding EXAS:  20
Total Market Value Held by ETFs:  $169.61M
Total Market Capitalization:  $2.31B
% of Market Cap. Held by ETFs:  7.35%

Open the EXAS Page at The Online Investor (in a new window) »

December 22, 2014    2:24 PM Eastern
Quotes delayed 20 minutes

Buy (3.20 out of 4)
56th percentile
(ranked higher than approx. 56% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.